FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  CRYO CELL INTERNATIONAL INC
2. Date of Event Requiring Statement (Month/Day/Year)
02/13/2018
3. Issuer Name and Ticker or Trading Symbol
Cord Blood America, Inc. [CBAI]
(Last)
(First)
(Middle)
700 BROOKER CREEK BLVD., SUITE 1800, 
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

OLDSMAR, FL 34677
6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 114,207,446 (1) (5)
D
 
Common Stock 16,268,554 (2) (5)
D
 
Common Stock 4,061,770 (3) (5)
D
 
Common Stock 25,000,000 (4) (5)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
CRYO CELL INTERNATIONAL INC
700 BROOKER CREEK BLVD., SUITE 1800
OLDSMAR, FL 34677
    X    
PORTNOY DAVID
700 BROOKER CREEK BLVD., SUITE 1800
OLDSMAR, FL 34677
    X    
Portnoy Mark L.
700 BROOKER CREEK BLVD.
ST. 1800
OLDSMAR, FL 34677
    X    
Gaines George
700 BROOKER CREEK BLVD., SUITE 1800
OLDSMAR, FL 34677
    X    

Signatures

/s/ David Portnoy, Individual, and Chief Executive Officer and Authorized Representative of Cryo-Cell, International, Inc. 02/21/2018
**Signature of Reporting Person Date

/s/ David Portnoy 02/21/2018
**Signature of Reporting Person Date

/s/ Mark Portnoy 02/21/2018
**Signature of Reporting Person Date

/s/ George Gaines 02/21/2018
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Shares owned solely by CRYO-CELL International, Inc.
(2) Shares owned solely by David I. Portnoy.
(3) Shares owned solely by Mark L. Portnoy.
(4) Shares owned solely by George Gaines.
(5) Messrs. Portnoy, Portnoy and Gaines, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.